I am curious, looking forward here, what -- in terms of the target capital structure over the medium term ... We do see promise in new logo as well, But in terms of key areas that we're focused on in ...

DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...

Nav1.7 is an important pain-related target, based on strong human genetic validation ... our ability to successfully develop and achieve milestones in our azetukalner and other pipeline and ...

Boomitm, the intelligent integration and automation leader, today announced the addition of two seasoned executives to its leadership team. The appointments come at a pivotal time for the company as ...

Air Force David Flosi discussed reoptimizing for Great Power Competition and the role of the Air Force and Space Force in ...

In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Assertio Therapeutics (ASRT – Research Report), with a price target of $3.00 ... focusing on stocks such as ...

Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report) today and set a price target of $45.00 ... defined as individuals who are unable ...

Researchers developed ultrasensitive nanoscale sensors for isoprene detection in breath, offering a non-invasive method for ...

India is not attending the two-day World Leaders Climate Action Summit (WLCAS) beginning Tuesday with country statements at ...

At this time, all participants have been placed in a listen-only mode. After the company completes their prepared remarks, the lines will be open to take your questions. [Operator instructions] Please ...

Donate at tcchristmasfund.com. Goal of 2024 Times Colonist fundraiser is to surpass the $1.12 million readers donated last ...

Supporter say the government needs a new tool to crackdown on nonprofits that support terrorism. Critics say the bill could ...